Softwr

Research · head to head

LabVantage vs Scispot

LabVantage logo

LabVantage

Research

Enterprise LIMS with integrated ELN and biobanking capability

From
On request
Rated
-
Full reviewWebsite
Scispot logo

Scispot

Research

No-code lab operating system combining LIMS, ELN and inventory for biotech teams

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: LabVantage enterprise implementation weight, with configuration and validation measured in many months; Scispot pricing is presented as four dollar sign bands with no figures, so a vendor whose marketing attacks competitor pricing opacity requires a discovery call before telling you its own numbers.
  • They diverge on capability: LabVantage covers Unified platform, Scispot covers No-code configuration.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which LabVantage and Scispot actually diverge.

Attributes where LabVantage and Scispot differ
AttributeLabVantageScispot
PlatformsWeb, Cloud, On-premiseWeb, API

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in LabVantage

  • Unified platform
  • Biobanking
  • Industry accelerators
  • Regulatory compliance
  • Web architecture

Only in Scispot

  • No-code configuration
  • LIMS and ELN together
  • Inventory management
  • Audit trails and e-signatures
  • API and data layer
  • Validation support
  • Integrations

Both cover

  • Instrument integration

What people use each for

The jobs each tool is most often brought in to do.

LabVantage

  • Laboratories wanting LIMS and ELN from one vendor rather than integrating twonot Scispot
  • Biobanks managing specimen provenance, consent and long-term storagenot Scispot
  • Pharmaceutical research organisations spanning discovery through QCnot Scispot
  • Multi-site laboratory networks standardising on a single platformnot Scispot

Scispot

  • A Series A biotech replacing a folder of spreadsheets before a partner or investor audit exposes the gapnot LabVantage
  • A diagnostics company that needs sample chain of custody and electronic signatures without a year-long LIMS implementationnot LabVantage
  • A contract research organisation configuring different workflows per client without buying a separate instance each timenot LabVantage
  • A computational team that wants laboratory data queryable through an API rather than exported by handnot LabVantage

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

LabVantage

  • Enterprise implementation weight, with configuration and validation measured in many months
  • Pricing is quote-based with no public entry point
  • The unified platform argument only pays off for laboratories that genuinely need all four capabilities; those needing only LIMS may find focused competitors better
  • Smaller installed base than LabWare, which matters in conservative laboratory procurement
  • Industry accelerators shorten implementation but do not remove the need for laboratory-specific configuration

Scispot

  • Pricing is presented as four dollar sign bands with no figures, so a vendor whose marketing attacks competitor pricing opacity requires a discovery call before telling you its own numbers.
  • Compliance capability is bundled into tier scope rather than itemised, which makes it hard to tell at purchase whether the tier you are quoted actually covers the Part 11 controls your auditor will ask for.
  • Validation remains your responsibility: the vendor supplies support and correctly states that no platform makes a lab compliant, but the documentation effort and its cost sit with your quality function.
  • It is a young and small vendor holding your primary scientific record, so business continuity, data escrow and full export guarantees need to be settled contractually rather than assumed.
  • Instrument integration breadth is narrower than the established LIMS vendors, so labs with older or unusual analysers may need custom connector work that undercuts the no-code promise.

Pricing, plan by plan

LabVantage

On request
  • LabVantage$undefined/year
    • LIMS
    • ELN
    • LES

Scispot

On request
  • Scispot$undefined/year
    • Custom annual pricing released after a discovery call
    • Four relative investment tiers shown only as dollar sign bands
    • Mid tier adds roles, e-signatures, approvals, audit trails and validation support

Which should you pick?

Choose LabVantage if

  • You need unified platform.
  • You work on Web, Cloud, On-premise.
  • You also want biobanking.
LabVantage review

Choose Scispot if

  • You need no-code configuration.
  • You work on Web, API.
  • You also want lims and eln together.
Scispot review

Questions people ask

Is LabVantage or Scispot better?
Neither clearly leads. LabVantage starts at On request and Scispot at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, LabVantage or Scispot?
LabVantage starts at On request and Scispot at On request.
Does LabVantage or Scispot run on more platforms?
LabVantage runs on Web, Cloud, On-premise. Scispot runs on Web, API.
What is LabVantage best used for?
LabVantage is most often used for laboratories wanting lims and eln from one vendor rather than integrating two, biobanks managing specimen provenance, consent and long-term storage, pharmaceutical research organisations spanning discovery through qc, multi-site laboratory networks standardising on a single platform. Of those, laboratories wanting lims and eln from one vendor rather than integrating two and biobanks managing specimen provenance, consent and long-term storage are not what Scispot is typically brought in for.
What can LabVantage do that Scispot cannot?
LabVantage covers Unified platform, Biobanking, Industry accelerators, Regulatory compliance. Scispot covers No-code configuration, LIMS and ELN together, Inventory management, Audit trails and e-signatures. Both handle Instrument integration.

Answered from the vendors’ own pages

LabVantage: What does the unified platform actually mean?

LIMS, electronic laboratory notebook, laboratory execution and scientific data management as one product. Laboratories that would otherwise integrate and validate four vendors avoid that work.

Scispot: How much does Scispot cost?

It does not publish figures. The pricing page shows four relative investment tiers as dollar sign bands, with real numbers given after a discovery call.

LabVantage: Is biobanking really different?

Yes. Specimen provenance, consent tracking and decades-long storage are distinct from test result management, and the number of platforms handling them properly is small.

Scispot: Does it support 21 CFR Part 11?

It can be configured for Part 11 controlled workflows with roles, e-signatures, approvals and audit trails from the mid tier, and it supports ALCOA+ principles. Validation of your configuration is still your responsibility.

LabVantage: What does it cost?

Not published. Enterprise annual licensing plus implementation, quoted on scope.

Scispot: Is it a LIMS or an ELN?

Both, plus inventory, in one subscription rather than separately licensed products.

LabVantage: Do the industry accelerators shorten implementation?

They help by supplying pre-configured workflows for a vertical. They do not remove laboratory-specific configuration or, in regulated settings, validation.

Scispot: Who is it not for?

Large regulated manufacturers with existing validated LIMS estates, and any lab that needs deep integration with an unusual analyser fleet.

LabVantage: How does it compare to LabWare?

LabWare has the larger installed base and deeper pharmaceutical QC dominance. LabVantage argues on the unified LIMS and ELN platform and on biobanking. Both are enterprise projects.

Share

Related pages

More on LabVantage

More on Scispot

Keep looking

Other head to heads